Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
skip to main content
research-article

An artificial intelligence approach to early predict non-ST-elevation myocardial infarction patients with chest pain

Published: 01 May 2019 Publication History

Highlights

The incidence of non-ST segment elevation myocardial infarction (NSTEMI) has been increased worldwide.
We developed an artificial intelligence approach to predict stable NSTEMI that would give valuable insight to reduce misdiagnosis in the clinical setting.
ANN prediction model showed a higher accuracy to predict NSTEMI patients.

Abstract

Background and Aims

Hospital admission rate for the patients with chest pain has already been increased worldwide but no existing risk score has been designed to stratify non-ST-elevation myocardial infarction (NSTEMI) from non-cardiogenic chest pain. Clinical diagnosis of chest pain in the emergency department is always highly subjective and variable. We, therefore, aimed to develop an artificial intelligence approach to predict stable NSTEMI that would give valuable insight to reduce misdiagnosis in the real clinical setting.

Methods

A standard protocol was developed to collect data from chest pain patients who had visited the emergency department between December 2016 and February 2017. All the chest pain patients with aged <20 years were primarily included in this study. However, STEMI, previous history of ACS, and out-of-hospital cardiac arrest were excluded from our study. An artificial neural network (ANN) model was then developed to predict NSTEMI patients. The accuracy, sensitivity, specificity, and receiver operating characteristic curve was used to measure the performance of this model.

Results

A total of 268 chest pain patients were included in this study; of those, 47 (17.5%) was stable NSTEMI, and 221 (82.5%) was unstable angina patients. Serval risk factors such as cardiac risk factor, systolic blood pressure, hemoglobin, corrected QT interval (QTc), PR interval, glutamic-oxaloacetic transaminase, glutamic pyruvic transaminase and troponin were independently associated with stable NSTEMI. The area under the receiver operating characteristic (AUROC) and accuracy of ANN were 98.4, and 92.86. Additionally, the sensitivity, specificity, positive predictive value, and negative predictive value of the ANN model was 90.91, 93.33, 76.92, and 97.67 respectively.

Conclusion

Our prediction model showed a higher accuracy to predict NSTEMI patients. This model has a potential application in disease detection, monitoring, and prognosis of chest pain at risk of AMI.

References

[1]
C.H. Liu, Y.C. Huang, Comparison of STEMI and NSTEMI patients in the emergency department, J. Acute Med. 1 (2011) 1–4.
[2]
R.Y. Hsia, Z. Hale, J.A. Tabas, A national study of the prevalence of life-threatening diagnoses in patients with chest pain, JAMA Internal Med. 176 (2016) 1029–1032.
[3]
J.H. Pope, T.P. Aufderheide, R. Ruthazer, R.H. Woolard, J.A. Feldman, J.R. Beshansky, et al., Missed diagnoses of acute cardiac ischemia in the emergency department, New Eng. J. Med. 342 (2000) 1163–1170.
[4]
J.T. Sakamoto, N. Liu, Z.X. Koh, N.X.J. Fung, M.L.A. Heldeweg, J.C.J. Ng, et al., Comparing HEART, TIMI, and GRACE scores for prediction of 30-day major adverse cardiac events in high acuity chest pain patients in the emergency department, Int. J. Cardiol. 221 (2016) 759–764.
[5]
R.J. Burns, R.J. Gibbons, Q. Yi, R.S. Roberts, T.D. Miller, G.L. Schaer, et al., The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis, J. Am. College Cardiol. 39 (2002) 30–36.
[6]
T.N. Martin, B.A. Groenning, H.M. Murray, T. Steedman, J.E. Foster, A.T. Elliot, et al., ST-segment deviation analysis of the admission 12-lead electrocardiogram as an aid to early diagnosis of acute myocardial infarction with a cardiac magnetic resonance imaging gold standard, J. Am. College Cardiol. 50 (2007) 1021–1028.
[7]
M. Loutfi, S. Ashour, E. El-Sharkawy, S. El-Fawal, K. El-Touny, Identification of high-risk patients with non-ST segment elevation myocardial infarction using strain doppler echocardiography: correlation with cardiac magnetic resonance imaging, Clinical Med. Insights 10 (2016) CMC. S35734.
[8]
D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, American heart association statistics committee and stroke statistics subcommittee, Heart disease and stroke statistics–2015 update: a report from the American Heart Association, Circulation 131 (2015) e29–e322.
[9]
J.-P. Bassand, C.W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernández-Avilés, et al., Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology, Eur. Heart J. 28 (2007) 1598–1660.
[10]
T. Mehmood, M.S. Al Shehrani, M. Ahmad, Acute coronary syndrome risk prediction of rapid emergency medicine scoring system in acute chest pain: an observational study of patients presenting with chest pain in the emergency department in Central Saudi Arabia, Saudi Med. J. 38 (2017) 900.
[11]
C.-Z. Gao, Q.-Q. Ma, J. Wu, R. Liu, F. Wang, J. Bai, et al., Comparison of the effects of ticagrelor and clopidogrel on inflammatory Factors, vascular endothelium functions and short-term prognosis in patients with Acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention: a pilot study, Cellular Physiol. Biochem. 48 (2018) 385–396.
[12]
P. de Araújo Gonçalves, J. Ferreira, C. Aguiar, R. Seabra-Gomes, TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACS, Eur. Heart J. 26 (2005) 865–872.
[13]
R.Y. Kwong, A.E. Arai, Detecting patients with acute coronary syndrome in the chest pain center of the emergency department with cardiac magnetic resonance imaging, Critical Pathways Cardiol. 3 (2004) 25–31.
[14]
S. Rajvanshi, R. Nath, M. Kumar, A. Gupta, N. Pandit, Correlation of corrected QT interval with quantitative cardiac troponin-I levels and its prognostic role in Non-ST-elevation myocardial infarction, Int. J. Cardiol. 240 (2017) 55–59.
[15]
E.H.F.R. Brunori, C.T. Lopes, A.M.R.Z. Cavalcante, V.B. Santos, J.d.L. Lopes, A.L.B.L.d. Barros, Association of cardiovascular risk factors with the different presentations of acute coronary syndrome, Revista latino-americana de enfermagem 22 (2014) 538–546.
[16]
C. Members, E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, et al., ACC/AHA guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina), Circulation 106 (2002) 1893–1900.
[17]
T. Keller, T. Zeller, D. Peetz, S. Tzikas, A. Roth, E. Czyz, et al., Sensitive troponin I assay in early diagnosis of acute myocardial infarction, New Engl. J. Med. 361 (2009) 868–877.
[18]
M.A. Daubert, A. Jeremias, The utility of troponin measurement to detect myocardial infarction: review of the current findings, Vascular Health Risk Manage. 6 (2010) 691.
[19]
M.C. Kontos, R. Shah, L.M. Fritz, F.P. Anderson, J.L. Tatum, J.P. Ornato, et al., Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients, J. Am. College Cardiol. 43 (2004) 958–965.
[20]
C.T. Chin, T.Y. Wang, S. Li, S.D. Wiviott, J.A. deLemos, M.C. Kontos, et al., Comparison of the prognostic value of peak creatine kinase‐mb and troponin levels among patients with acute myocardial infarction: a Report from the acute coronary treatment and intervention outcomes network registry–get with the guidelines, Clinical Cardiol. 35 (2012) 424–429.
[21]
J. Santopinto, K.A. Fox, R.J. Goldberg, A. Budaj, G. Pinero, A. Avezum, et al., Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE), Heart 89 (2003) 1003–1008.
[22]
H. Narayan, O.S. Dhillon, P.A. Quinn, J. Struck, I.B. Squire, J.E. Davies, et al., C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: leicester Acute Myocardial Infarction Peptide II (LAMP II) study, Clinical Sci. 121 (2011) 79–89.

Cited By

View all
  • (2022)Fully automated 2D and 3D convolutional neural networks pipeline for video segmentation and myocardial infarction detection in echocardiographyMultimedia Tools and Applications10.1007/s11042-021-11579-481:26(37417-37439)Online publication date: 1-Nov-2022

Index Terms

  1. An artificial intelligence approach to early predict non-ST-elevation myocardial infarction patients with chest pain
          Index terms have been assigned to the content through auto-classification.

          Recommendations

          Comments

          Information & Contributors

          Information

          Published In

          cover image Computer Methods and Programs in Biomedicine
          Computer Methods and Programs in Biomedicine  Volume 173, Issue C
          May 2019
          185 pages

          Publisher

          Elsevier North-Holland, Inc.

          United States

          Publication History

          Published: 01 May 2019

          Author Tags

          1. Acute coronary syndrome
          2. Chest pain
          3. Non-ST elevated MI
          4. Artificial neural network

          Qualifiers

          • Research-article

          Contributors

          Other Metrics

          Bibliometrics & Citations

          Bibliometrics

          Article Metrics

          • Downloads (Last 12 months)0
          • Downloads (Last 6 weeks)0
          Reflects downloads up to 17 Feb 2025

          Other Metrics

          Citations

          Cited By

          View all
          • (2022)Fully automated 2D and 3D convolutional neural networks pipeline for video segmentation and myocardial infarction detection in echocardiographyMultimedia Tools and Applications10.1007/s11042-021-11579-481:26(37417-37439)Online publication date: 1-Nov-2022

          View Options

          View options

          Figures

          Tables

          Media

          Share

          Share

          Share this Publication link

          Share on social media